1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characterisation of co-eluting isomeric metabolites using an ion mobility enabled QTof mass spectrometer. Issue 1 (January 2017) Authors: Clayton, R.; Kendrick, J.; Holdsworth, C.; McKenzie, D.; Weston, D.; Tomczyk, N.; Palmer, M.; Hewitt, D. Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017)Supplement Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Differentiation of acyl and phenolic glucuronide metabolites using ion mobility derived collision cross section measurements. Issue 1 (January 2017) Authors: Kendrick, J.; Mckenzie, D.; Clayton, R.; Weston, D.; Holdsworth, C.; Tomczyk, N.; Palmer, M.; Hewitt, D. Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017)Supplement Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Spatiotemporal Limitations of Data‐Driven Modeling: An ISINGLASS Case Study. Issue 9 (30th August 2022) Authors: Burleigh, M.; Lynch, K.; Zettergren, M.; Clayton, R. Journal: Journal of geophysical research Issue: Volume 127:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗